GD2 CAR T / University College London, Great Ormond Street Hospital for Children - LARVOL DELTA

MAGNETO: Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: University College, London | Not yet recruiting ➔ Recruiting | Initiation date: Jan 2024 ➔ Apr 2024

Enrollment open • Trial initiation date • CNS Tumor • Neuroblastoma • Oncology • Solid Tumor

CARMIGO: CAR T Cells to Target GD2 for DMG (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: University College, London | Not yet recruiting ➔ Recruiting

CAR T-Cell Therapy • Enrollment open • Brain Cancer • CNS Tumor • Diffuse Midline Glioma • Glioma • Oncology • Solid Tumor

MAGNETO: Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: University College, London

New P1 trial • CNS Tumor • Neuroblastoma • Neuroendocrine Tumor • Oncology • Solid Tumor

CARMIGO: CAR T Cells to Target GD2 for DMG (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: University College, London | Initiation date: Feb 2023 ➔ May 2023

CAR T-Cell Therapy • Trial initiation date • Brain Cancer • CNS Tumor • Diffuse Midline Glioma • Glioma • Oncology • Solid Tumor

CARMIGO: CAR T Cells to Target GD2 for DMG (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: University College, London

CAR T-Cell Therapy • New P1 trial • Brain Cancer • Diffuse Midline Glioma • Glioma • Oncology • Solid Tumor